Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

GEVELOT S.A.: Number of Shares and Voting rights  4 January 2024
GEVELOT S.A.: Number of Shares and Voting rights 4 January 2024
GEVELOT S.A.: Number of Shares and Voting rights 4 January 2024
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31
Kaufman & Broad SA: HALF-YEAR LIQUIDITY CONTRACT STATEMENT FOR KAUFMAN & BROAD SA _ 2023, decembre 31
EQS-News: Abivax 2024 Financial Communication Calendar
EQS-News: Abivax 2024 Financial Communication Calendar
EQS-News: Abivax 2024 Financial Communication Calendar
Poxel Announces its Financial Calendar for 2024: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces its Financial Calendar for 2024


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Poxel Provides Corporate Update: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Provides Corporate Update


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Transgene Announces Upcoming Investor Meetings: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Announces Upcoming Investor Meetings


Regulatory News:



TRANSGENE (Paris:TNG) today announces that Management will participate in several investor events in the upcoming investor events, as set out below.



Transgene will meet

Prodware: Prodware steps up its expansion in Europe with the acquisition of Nut Consulting in Spain
Prodware: Prodware steps up its expansion in Europe with the acquisition of Nut Consulting in Spain
Prodware: Prodware steps up its expansion in Europe with the acquisition of Nut Consulting in Spain
FOCUS ENTERTAINMENT: Geoffroy Sardin's Appointment as Deputy CEO of Focus Entertainment
FOCUS ENTERTAINMENT: Geoffroy Sardin's Appointment as Deputy CEO of Focus Entertainment
FOCUS ENTERTAINMENT: Geoffroy Sardin's Appointment as Deputy CEO of Focus Entertainment
FOCUS ENTERTAINMENT: Creation of Scripteam and acquisition of stakes in two studios to build an audiovisual platform
FOCUS ENTERTAINMENT: Creation of Scripteam and acquisition of stakes in two studios to build an audiovisual platform
FOCUS ENTERTAINMENT: Creation of Scripteam and acquisition of stakes in two studios to build an audiovisual platform
FOCUS ENTERTAINMENT: H1 2023/2024 results : strong growth in revenue and lower profitability
FOCUS ENTERTAINMENT: H1 2023/2024 results : strong growth in revenue and lower profitability
FOCUS ENTERTAINMENT: H1 2023/2024 results : strong growth in revenue and lower profitability
RALLYE S.A.: Appeal against the decision of the Sanctions Commission of the French Financial Market Authority
RALLYE S.A.: Appeal against the decision of the Sanctions Commission of the French Financial Market Authority
RALLYE S.A.: Appeal against the decision of the Sanctions Commission of the French Financial Market Authority
FOCUS ENTERTAINMENT: Announces, at the Game Awards, the release date of WARHAMMER 40,000: SPACE MARINE 2 on September 9th, 2024 - A new impactful trailer for Banishers : Ghosts of New Eden
FOCUS ENTERTAINMENT: Announces, at the Game Awards, the release date of WARHAMMER 40,000: SPACE MARINE 2 on September 9th, 2024 - A new impactful trailer for Banishers : Ghosts of New Eden
FOCUS ENTERTAINMENT: Announces, at the Game Awards, the release date of WARHAMMER 40,000: SPACE MARINE 2 on September 9th, 2024 - A new impactful trailer for Banishers : Ghosts of New Eden
Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Strengthens its Leadership Team to Accelerate its Growth Strategy


Regulatory News:



Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the

EQS-News: Abivax announces the resumption of its liquidity contract
EQS-News: Abivax announces the resumption of its liquidity contract
EQS-News: Abivax announces the resumption of its liquidity contract
Verimatrix XTD gewinnt den TITAN Business Award in Gold für Cybersicherheit: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD gewinnt den TITAN Business Award in Gold für Cybersicherheit


Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheit für die moderne vernetzte Welt, gab heute bekannt, dass seine Verimatrix Extended Threat Defense (XTD)-Lösung für

Verimatrix XTD Wins Gold TITAN Business Award for Cybersecurity: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD Wins Gold TITAN Business Award for Cybersecurity


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that its Verimatrix Extended

EQS-News: Abivax to participate in the Piper Sandler 35th Annual Healthcare Conference
EQS-News: Abivax to participate in the Piper Sandler 35th Annual Healthcare Conference
EQS-News: Abivax to participate in the Piper Sandler 35th Annual Healthcare Conference
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023


Regulatory News:



POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Transgene Reports Business Update and Q3 2023 Financial Position: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene Reports Business Update and Q3 2023 Financial Position


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update and its

Verimatrix gewinnt den 2023 Top Infosec Innovator Award: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix gewinnt den 2023 Top Infosec Innovator Award


Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheit für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen bei den diesjährigen Top Infosec

Verimatrix Wins 2023 Top Infosec Innovator Award: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Wins 2023 Top Infosec Innovator Award


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it was named a Hot Company in

Axway Software: Strong Revenue Performance in Q3 2023: https://mms.businesswire.com/media/20210427006220/en/800734/5/Axway_logo.jpg
Axway Software: Strong Revenue Performance in Q3 2023


Regulatory News:



In Q3 2023, as in the first 9 months of the year, Axway (Euronext: AXW.PA) recorded an excellent sales performance characterized by the dynamism of its subscription offerings

RALLYE S.A.: Opening of ad hoc proceedings
RALLYE S.A.: Opening of ad hoc proceedings
RALLYE S.A.: Opening of ad hoc proceedings
EQS-News: Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market
EQS-News: Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market
EQS-News: Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market
EQS-News: Abivax announces trading resumption of its ordinary shares on Euronext Paris
EQS-News: Abivax announces trading resumption of its ordinary shares on Euronext Paris
EQS-News: Abivax announces trading resumption of its ordinary shares on Euronext Paris